Vg Life Sciences Inc (VGLS)

OTC Markets
0.000
0.000(0.00%)
  • वॉल्यूम:
    0
  • बोली/पुछे:
    0.000/0.000
  • दिन की रेंज:
    0.000 - 0.000

VGLS समीक्षा

पिछला बंद
0.001
दिन की रेंज
-
आय
-
खुला
-
52 सप्ताह रेंज
0-0.008
ईपीएस
-0.07
वॉल्यूम
0
मार्केट कैप
276.88K
लाभांश (यील्ड)
N/A
(N/A)
औसत वॉल्यूम (3एम)
56,468,309
पी/ई अनुपात
-
बीटा
1.24
1- वर्ष बदलाव
-90%
बकाया शेयर
2,768,782,721
अगली कमाई तिथि
-
Vg Life Sciences Inc पर आपकी भावना क्या है?
या
अभी बाज़ार बंद हैं। वोटिंग बाजार का समय के दौरान खुली है।

Vg Life Sciences Inc कंपनी प्रोफाइल

Vg Life Sciences Inc कंपनी प्रोफाइल

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.

और पढ़ें

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजमजबूत विक्रयमजबूत विक्रय
तकनीकी संकेतकतटस्थमजबूत विक्रय
सारांशबेचनामजबूत विक्रय